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Peptides containing phosphoseryl residues can be modified by removal of the phosphate groups via B-elimination fol- 
lowed by addition of pyridoxamine to the resulting dehydroalanyl residue. Peptides containing the modified residues can 
be detected at nanomole levels by monitoring absorbance at 328 nm or at picomole levels by monitoring fluorescence. 
Photolysis of the modified pcptide converts the pyridoxamino adduct to a form which can be readily identified after 
Edman degradation. 
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1. INTRODUCTION alanine, cysteic acid, S-ethanolcysteine and S- 
ethylcysteine residues, respectively. 
Because of the important role of protein 
phosphorylation in cellular regulation [1,2] it is 
often of interest to identify the phosphorylated 
residue. This task has proven difficult since 
phosphorylated residues are not readily identified 
in standard amino acid sequencing procedures [3]. 
The most satisfactory resolution to this problem to 
date has involved modification of the phos- 
phoserine prior to sequence analysis. The pro- 
cedure to modify the phosphoserine utilizes two 
steps in which the phosphoserine residue under- 
goes p-elimination under alkaline conditions to 
form a dehydroalanyl residue followed by addition 
of an appropriate nucleophile across the un- 
saturated bond to form a stable adduct. Some of 
the nucleophilic reagents that have been used in 
this procedure include methylamine [4,5], sodium 
sulfide [6], mercaptoethanol [5], and ethanethiol 
[5]. These nucleophiles react with the dehydro- 
alanine intermediate forming &methylamino- 
In many cases, it is important to be able to easily 
identify phosphoserine-containing peptides, either 
to construct phosphopeptide maps or to facilitate 
their purification for sequence analysis. This is 
simple if the peptides are labelled with 32P, but dif- 
ficult if the peptides are not radioactive. Although 
peptide-bound phosphate can be determined col- 
orimetrically, the method is tedious and requires 
nanomole quantities of peptides. It occurred to us 
that use of the p-elimination reaction followed by 
addition of a chromophore would enable one to 
identify and quantify the peptides of interest based 
on the absorbance or fluorescence properties of the 
chromophore. We report here on the successful use 
of pyridoxamine, one of the Be-vitamers, as a 
reagent for identifying and sequencing phos- 
phoserine-containing peptides. 
2. MATERIALS AND METHODS 
2. I Materials 
Correspondence address: E.M. Reimann, Department of Kemptide (LRRASLG) and pyridoxamine dihydrochloride 
Biochemistry, Medical College of Ohio, Toledo, OH 43699, were obtained from Sigma. The cGMP-dependent protein 
USA kinase peptide substrate (cG-peptide) (RKRSRAE) was obtain- 
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ed from Peninsula. The catalytic subunit of the CAMP- 
dependent protein kinase was prepared according to the pro- 
cedure of Reimann and Beham [7]. 2,3-Diaminopropionic acid 
was purchased from Aldrich. The PTH-2,3-diaminopropionic 
acid derivative was prepared according to the procedure of Tarr 
181. 
2.2. Peptide phosphorylation 
The synthetic peptide (300 PM) was incubated with 365 PM 
ATP, 18.2 mM magnesium acetate and 15-40 gg protein kinase 
(catalytic subunit)/ml for 60 min at 25°C. 
2.3. Preparation of the modified peptide 
&Elimination of the phosphopeptide (260pM) was carried 
out in the presence of 0.1 N NaOH and 0.1 M SrCl2 [9] by in- 
cubating for 30 min at 40°C. The resulting dehydroalanyl 
residue was converted to a pyridoxaminoalanyl residue by ad- 
ding 0.25 vols of 0.5 M pyridoxamine dihydrochloride, 
0.75 vols of 1 .O M 3-(cyclohexylamino)-1-propanesulfonic acid 
(CAPS), pH 11 .O, 0. IS vols of 1 N NaOH and 0.35 vols of Hz0 
to the P-eliminated peptide (100 PM) solution and incubating 
for 180 min at 40°C. The reaction was stopped by acidification 
with HCI to approx. pH 4. 
Formation of the o-eliminated peptides and final addition 
products was analyzed by shifts in the retention times of the 
modified peptides on reversed phase HPLC monitored at 
206 nm. The peptides containing dehydroalanyl or pyridox- 
aminoalanyl residues also were monitored at 241 nm [lo] and 
328 nm, respectively. Fluorescence was monitored on an ABI 
Kratos Spectroflow 980 detector using a 295 nm excitation max- 
imum and 370 nm cut off emission filter. 
2.4. Reversed phase HPLC analysis 
Peptides were analyzed and isolated on Crs reversed phase 
columns (SynChropak RPP, 250 x 4.1 mm; Brownlee MPLC 
Analytical Cartridges, 30 x 4.6 mm and 100 x 4.6 mm). 
Following a 5 or 10 min isocratic wash with 0.1% 
trifluoroacetic acid (TFA), peptides were eluted with a gradient 
containing increasing concentrations of acetonitrile/0.08% 
TFA at a flow rate of 1 ml/min. Separation times varied depen- 
ding on the column used. 
2.5. Irradiation of the peptides containing pyridoxaminoalanyl 
residues 
The peptide containing the pyridoxamino moiety was isolated 
on a reversed phase HPLC column, dried under vacuum, 
resuspended in 40 mM potassium phosphate, pH 7.0, contain- 
ing 0.2 mM EDTA and exposed to a 30 W fluorescent light at 
10 cm for 8-12 h. The peptide was reisolated by reversed phase 
chromatography for amino acid composition and amino acid 
sequence analysis. 
2.6. Amino acid composition 
The peptides were hydrolyzed in 6 N HCI at 110°C for 22 h. 
Amino acid composition analysis was obtained with a Beckman 
amino acid analyzer (model 6300) using ninhydrin chemistry. 
2.7. Amino acid sequence 
Amino acid sequence analysis was performed on an Applied 
Biosystems 470 A gas-phase sequencer. PTH-amino acid 
derivatives were analyzed on a Waters model 840 HPLC system 
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and NOVA-PAK cl8 reversed phase column, utilizing the 
Waters PTH-analysis program. 
2.8. Fast atom bombardment mass spectrometry 
Positive and negative ion fast atom bombardment mass spec- 
tra of modified Kemptide were obtained using a Kratos MS-50 
mass spectrometer with a thioglycerol matrix, a post accelera- 
tion detector and calibration with CsI cluster ions. The accuracy 
was + 0.5 Da. 
3. RESULTS 
The hexapeptide substrate for CAMP-dependent 
protein kinase, Kemptide (LRRASLG), was used 
as the model peptide for the development of the 
modification procedure. The various forms of the 
peptide, phosphokemptide, unmodified kemptide, 
and the dehydroalanyl form can be separated and 
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Fig. 1. Analysis of kemptide containing pyridoxaminoalanine. 
3 nmol of the dehydroalanine form of kemptide (D-K) were 
partially reacted with pyridoxamine to form the addition 
product (Be-K) and the resulting mixture was separated on a 
reversed phase column and monitored at 206 nm (panel A) or 
328 nm (panel B). 
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analyzed by Crs reversed phase HPLC. Using this 
analysis procedure, it was demonstrated that /?- 
elimination of the phosphokemptide was complete 
within 30 min under the reaction conditions 
specified in section 2. The formation of the addi- 
tion product (Bh-K) from the dehydroalanine form 
of the peptide (D-K) can be monitored at 206 nm 
(fig.lA) as well as the identifiable wavelength for 
the pyridoxamino adduct (328 nm) (fig.lB). The 
product appears as a doublet which presumably 
represents stereoisomers since analysis of each 
peak gave identical amino acid compositions. In 
some instances the two forms were not resolved. 
The effect of pH on the addition reaction is 
shown in fig.2. In the pH range 10.0-11.0 
(fig.2A), using a sodium borate buffer instead of 
CAPS, the rate of the addition reaction increased 
steadily with increasing pH values. Beyond pH 
11.0, where excess NaOH was added to raise the 
pH (fig.2B), the rate of the addition reaction 
decreased with increasing pH. This became 
especially apparent with longer reaction times, as a 
biphasic process was apparent around pH 12. A 
plot of the 50 min time points for all pH values 
tested demonstrated that over this period the reac- 
tion rate was maximal and relatively constant in 
the pH range 10.75-12.5 (fig.2C). To minimize 
adverse effects of high pH on the reaction rates a 
pH range of 10.75-11.0 appears optimal. The 
reaction rate was proportional to the concentration 
of pyridoxamine between 2 and 50 mM 
pyridoxamine. 
B 
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Fig.3 correlates formation of the product with 
decreased amounts of the unreacted dehydro- 
alanine form of the peptide. The data on fig.3 are 
plotted to demonstrate that the formation of 
product, monitored at both 206 nm and 328 nm, 
was closely paralleled by a decrease in the dehydro- 
alanyl form monitored at 206 nm. At pH 10.75 
and 50 mM pyridoxamine, the reaction was vir- 
tually complete in 180 min at 40°C. In the absence 
of pyridoxamine, the dehydroanalyl form of the 
kemptide was stable at pH 10.75 over the 5 h in- 
cubation period. To increase the buffering capa- 
city, a CAPS buffer at pH 11.0 was used in 
subsequent studies with identical results. 
Under the above conditions, modification of the 
cG-peptide resulted in the formation of two 
product peaks of approximately equal distribu- 
tion. Only one peak showed absorbance at 328 nm, 
representing the pyridoxaminoalanyl form of the 
peptide. Amino acid compositional analysis show- 
ed that the other peak represented a lysinoalanyl 
form of the peptide where the E-amino group of 
lysine added across the unsaturated bond of the 
dehydroalanyl residue [ 111. Succinylation of the 
peptide prior to modification prevented the forma- 
tion of this alternate form. Studies on another pep- 
tide indicated that formation of lysinoalanyl 
residues could be minimized if pyridoxamine was 
present during p-elimination. 
The sensitivity of the analysis procedure, 
monitoring absorbance at 328 nm, is limited to ap- 
prox. 0.2 nmol of the modified peptide. Since 
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Fig.2. The effect of pH on the rate of the addition reaction. The dehydroalanine form of kemptide was modified as in section 2 except 
that borate buffer or NaOH was added to the indicated pH. 3 nmol aliquots of the peptide were removed from the reaction mixture 
at the indicated times and were analyzed by reversed phase HPLC. Results from A and B are presented as percent of the dehydroalanine 
form remaining. (A) A 0.15 M sodium borate buffer system was used for pH 10.0 (O), 10.25 (A), 10.75 (A), and 11.0 (m). (B) Excess 
NaOH was used in the higher pH range, pH 11.8 (o), 12.1 (*), 12.5 (0). and 12.8 (0). (C) Amount of product formed in 50 min as 
a function of pH. 
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Fig.3. (A) Time course of the addition reaction. 
Dehydroalanine form of kemptide (0.1 mM), 0.15 M sodium 
borate pH 10.75, and 50 mM pyridoxamine were incubated at 
40°C for the indicated times. Peptides containing 
dehydroalanyl ( W) and pyridoxaminoalanyl (H) 
residues were monitored at 206 nm on reversed phase HPLC as 
shown in panel B. Pyridoxaminoalanyl form was also 
monitored at 328 nm (m---m). The stability of the 
dehydroalanine intermediate at this pH was measured in the 
absence of pyridoxamine (A . . . A). (Absorbance values are 
corrected to a volume of 1 ml for each of the peaks.) (B) HPLC 
chromatograms of some of the time course data (0, 30, 60, 
180 min) represented in panel A. Unmodified form (K), 
dehydroalanyl form (D), and pyridoxaminoalanyl form (P) of 
kemptide were monitored at 206 nm. 
pyridoxamine and its derivatives are known to be 
fluorescent [ 121, increasing the detection sensitivity 
by monitoring fluorescence of the addition 
product was examined. Fluorescence monitoring 
gave approx. lOO-fold greater sensitivity over ab- 
sorbance measurements at 328 nm as shown by the 
detection of 11 pmol of the modified kemptide 
(fig.4). 
Automated sequence analysis of the peptide 
modified with pyridoxamine failed to yield an 
identifiable product for the modified residue, in- 
dicating that the PTH derivative is not stable, is 
not extracted in the standard Edman degradation 
method, or is not detected by the PTH analysis 
procedure. In order to circumvent this problem we 
exposed kemptide containing the pyridoxamino 
moiety to fluorescent light, since photolysis of pro- 
teins containing reduced, pyridoxylated lysyl 
residues regenerates free lysyl residues [ 131. Light 
exposure of modified kemptide resulted in a time- 
dependent decrease in the amount of peptide ab- 
sorbing at 328 nm and an increase in the amount 
of a slightly more hydrophilic form of the peptide 
which absorbed only at 206 nm. Photolysis of the 
peptide was complete in 8 h with a 30 W fluores- 
cent light. When the light-exposed modified kemp- 
tide was subjected to standard Edman 
degradation, the PTH-derivative of the modified 
phosphoserine appeared in cycle 5 as a strong 
signal eluting just prior to DPTU (fig.5). The 
modified residue is resolved from the other amino 
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Fig.4. Fluorescence monitoring of the pyridoxamine peptide. 
An aliquot of a reaction mixture containing 11 pmol of the 
pyridoxaminoalanine form of kemptide was analyzed by 
reversed phase HPLC and monitored for fluorescence. 
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Fig.5. Sequence analysis of the pyridoxaminoalanyl form of kemptide after light exposure. 11 nmol of the modified peptide were 
subjected to Edman degradation and PTH-amino acid analysis. The peak in cycle 5 (*) represents the PTH-derivative of the modified 
phosphoserine. 
acids and elutes between valine and tryptophan 
PTH-derivatives (fig.6). Similar analysis of the 
modified cG-peptide gave the same PTH derivative 
at the appropriate cycle. 
The structure of the photolysis product has not 
been established with certainty but a tentative iden- 
tification can be made. Based on the findings of 
Ritchey et al. [13] the anticipated product is 
aminoalanine. Fast atom bombardment analysis of 
kemptide after modification and photolysis in- 
dicated a mass of 770 as expected if an 
aminoalanine residue were generated. Furthermore 
the PTH derivative of the modified serine eluted in 
the same position as the PTH derivative formed 
from PITC and ,8-aminoalanine. However, acid 
hydrolysis of three different phosphopeptides that 
had been subjected to p-elimination, addition of 
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Fig.6. Separation of the PTH-derivatives of the modified and 
standard amino acyl residues. The PTH-derivative (lower 
panel) of the light-exposed pyridoxaminoalanyl residue (cycle 5, 
fig.5) was resolved from the standard PTH-amino acids (upper 
panel). 
1 - 
* 
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pyridoxamine and photolysis failed to yield an 
amino acid corresponding to ,&aminoalanine 
whereas ,&aminoalanine subjected to the condi- 
tions of acid hydrolysis yielded a ninhydrin- 
positive peak that eluted just after histidine when 
analyzed as described in section 2. One possible ex- 
planation for these results is that the product is (Y- 
aminoalanine rather than &aminoalanine and that 
a-aminoalanine is not stable under the conditions 
of acid hydrolysis. 
4. DISCUSSION 
The procedure for chemically modifying 
phosphoserine residues differs from previously 
reported &elimination-addition methods in the use 
of a chromophore. Pyridoxamine was selected as 
the chromophore so that the modification could be 
utilized for both peptide mapping and amino acid 
sequencing of phosphoserines contained in pep- 
tides and proteins. Photolysis of the pyridoxamino 
moiety renders the peptide suitable for amino acid 
sequence analysis and also renders the peptide 
slightly more hydrophilic, which generally should 
allow one to separate it from any contaminating 
peptides via reversed phase chromatography. This 
would be a particularly useful final purification 
step when the modified peptides are isolated from 
whole protein digests. 
In all peptides and proteins examined thus far, 
60 min was sufficient for complete &elimination 
of all phosphoserine residues. However, in some 
instances the modification reaction may not go to 
completion because the rate of &elimination for a 
given residue differs based on its surrounding 
amino acid environment [14]. Although the ,&- 
elimination reaction is relatively specific for 
phosphoserine, phosphothreonine residues have 
been shown to undergo &elimination, but at a 
reduced rate whep compared to phasphoserjnes 
[14]. Likewise, 0-glycosylated residues will also 
undergo &elimination and, in the case of O- 
glycoserine, will form the same dehydroalanine 
derivative observed with phosphoserine [IO]. Cys- 
teine residues may also p-eliminate under alkaline 
conditions, forming the dehydroalanine in- 
termediate [IO]. The sulfhydryl group of an intact 
cysteine or the e-amino group of a neighboring 
lysine may act as an internal nucleophile and add 
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across the unsaturated dehydroalanine bond, for- 
ming a lanthionine [IO] or lysinoalanine residue 
[ 1 I], respectively. Therefore, modification of cys- 
teine and/or lysine residues prior to P-elimination 
may be required to avoid these complications. 
The reduced reactivity of some phosphoserines 
and the lack of absolute specificity are not serious 
limitations for many of the potential applications 
of this method. This modification procedure has 
the potential for peptide mapping of phosphopro- 
teins as well as sequence analysis of the resulting 
phosphopeptides. It does not require the use of 
radioisotopes or prior knowledge of the primary 
structure of the protein to detect phosphoserine 
containing peptides and, utilizing the fluorescent 
characteristics of the chromophore, can be used to 
detect pmol amounts of the modified peptides. 
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